Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-11-2006 | Editorial

¹²⁴I in PET imaging: impact on quantification, radiopharmaceutical development and distribution

Authors: Andreas Bockisch, Lutz Freudenberg, Sandra Rosenbaum, Walter Jentzen

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 11/2006

Excerpt

This is an exciting time for nuclear medicine. For various reasons, increasing attention is being paid to the interesting field of molecular imaging, which has always essentially been the focus of nuclear medicine. …

Knust EJ, Dutschka K, Weinreich R. Preparation of ¹²⁴I solutions after thermodistillation of irradiated ¹²⁴TeO₂ targets. Appl Radiat Isot 2000;52:181–4PubMedCrossRef

Freudenberg LS, Antoch G, Jentzen W, Pink R, Knust J, Gorges R, et al. Value of ¹²⁴I-PET/CT in staging of patients with differentiated thyroid cancer. Eur Radiol 2004;14:2092–8PubMedCrossRef

Dingli D, Kemp BJ, O’Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of nis gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol 2005;19:1–8

Eschmann SM, Reischl G, Bilger K, Kupferschlager J, Thelen MH, Dohmen BM, et al. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders bymeans of iodine-124 and PET. Eur J Nucl Med Mol Imaging 2002;29:760–7PubMedCrossRef

Herzog H, Tellman L, Qaim SM, Spellerberg S, Schmid A, Coenen HH. PET quantitation and imaging of the non-pure positron-emitting iodine isotope ¹²⁴I. Appl Radiat Isot 2002;56:673–9PubMedCrossRef

Title: 124I in PET imaging: impact on quantification, radiopharmaceutical development and distribution
Authors: Andreas Bockisch
Lutz Freudenberg
Sandra Rosenbaum
Walter Jentzen
Publication date: 01-11-2006
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 11/2006
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-006-0208-1

2024 ASCO Annual Meeting

Springer Medicine

¹²⁴I in PET imaging: impact on quantification, radiopharmaceutical development and distribution

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2006

Preparation and evaluation of 89Zr-Zevalin for monitoring of 90Y-Zevalin biodistribution with positron emission tomography

Auger radiation targeted into DNA: a therapy perspective

Radiation protection in radionuclide therapies with 90Y-conjugates: risks and safety

Assessment of the short-lived non-pure positron-emitting nuclide 120I for PET imaging

Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT?

Scintigraphic imaging of P-glycoprotein expression with a radiolabelled antibody